enzh-TWfrdeitjaptrues

Genomics, Signaling, and Treatment of Waldenstrom's MacroglobulinemiaWaldenström’s macroglobulinemia (WM) is a distinct B-cell malignancythat results from the accumulation, predominantly in the bone marrow, of clonally related B type lymphocytes, lymphoplasmacytic cells and plasma cells which secrete a monoclonal IgM protein.1 This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the World Health Organization classification system.2 Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG and non-secreting LPL ...

Latest Bing Center News

International Patients

International Patients

Every year, thousands of people with cancer from around the world come to Dana-Farber for their care. If you live outside the US and wish to make an appointment at Dana-Farber Cancer Institute, please complete this online form or contact the appropriate person below:

Read more..

UPDATE: Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

UPDATE: Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

Workshop Date and Time: Wednesday, April 21, 2021, 12:30 – 1:30pm (EDT). AN AUDIO RECORDING IS NOW AVAILABLE! This will be the 8th collaboration between IWMF and CancerCare in a Connect® Education Workshop on WM. CancerCare, is the leading national organization in the U.S. providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.

Read more..

LLS Patient Education: Waldenstrom’s Macroglobulinemia Update

LLS Patient Education: Waldenstrom’s Macroglobulinemia Update

Please join LLS and Memorial Cancer Institute for a free virtual education program for patients and their families. Presenters will discuss the latest advances in Waldenstrom’s Macroglobulinemia from diagnosis to living with the disease.

Read more..

Ask the Doctors LIVE: WM and the COVID Vaccine

Ask the Doctors LIVE: WM and the COVID Vaccine

March 31, 2021 Webinar: Our IWMF experts will share an update on the status of existing vaccines and others in development. This interactive LIVE question and answer session will explain side effects and recommendations for WM patients.

Read more..

Treatment Advancements are Improving Survivorship and Prompting Hope

Treatment Advancements are Improving Survivorship and Prompting Hope

Is a cure for Waldenstrom macroglobulinemia on the horizon? In the past several decades Waldenstrom’s survivorship has vastly improved due to safer and more effective treatment drugs. Could this indicate that a cure might be within reach?

Read more..

New Treatment Options for Waldenstrom Macroglobulinemia

New Treatment Options for Waldenstrom Macroglobulinemia

New combination drug regimens are being studied for the treatment of Waldenstrom macroglobulinemia (WM). In this segment, Dr. Jorge Castillo, MD, of Dana-Farber Cancer Institute updates patients on the information presented at the recent American Society of Hematology (ASH) conference and suggests that Waldenstrom patients pay attention to the combination of ibrutinib and rituximab (INNOVATE Study), that have shown faster and deeper responses over time versus rituximab alone.

Read more..

A 70-year-old New Brunwick man to walk 300 kilometres for rare cancer awareness

A 70-year-old New Brunwick man to walk 300 kilometres for rare cancer awareness

A Rothesay man fighting a rare cancer is stepping up to raise awareness about the disease. And as Travis Fortnum reports, he’s planning a month-long walk to do it.

Read more..

2021 IWMF Global Educational Webinar with Dr. Stephen Ansell & Dr. Jorge Castillo

2021 IWMF Global Educational Webinar with Dr. Stephen Ansell & Dr. Jorge Castillo

Our IWMF experts will share an update on the status of existing COVID-19 vaccines and others in development. This interactive LIVE question and answer session will explain side effects and recommendations for WM patients.

Read more..

Clinical Trials Are Moving Out of the Lab and Into Peopleʼs Homes

Clinical Trials Are Moving Out of the Lab and Into Peopleʼs Homes

After the pandemic forced thousands of trials to shut down, researchers found clever ways to conduct human studies remotely — while reaching more people, quickly and cheaply.

Read more..